VION Biosciences Closes Acquisition of CTL, Strengthening Functional Immune Monitoring Capabilities

VION Biosciences ("VION"), a life sciences company building differentiated capabilities across research, diagnostics, and ...
Labroots

Intratumoral cDC1-T Cell Clusters Serve as Sites of Local Costimulation to Enhance CTL-Mediated Tumor Rejection

Understanding how immune cells coordinate within the tumor microenvironment is essential for developing effective cancer immunotherapies. While CD8⁺ cytotoxic T cells are central to anti-tumor ...